Patents by Inventor Om Parkash Suri
Om Parkash Suri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7794753Abstract: The present invention relates to a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) in the ratio ranging between 1:7 to 7:1 (w/w), useful in hepatoprotection; and a process for the preparation of a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) useful in hepatoprotection, said process comprising steps of grounding the particles of the t-TCA and AP into fine particles, mixing the fine particles in ratio ranging between 1:7 to 7:1 (w/w), and grinding the mixture to obtain formulation, and also, a method of hepatoprotection of a subject using the synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP), said method comprising the steps of administering the formulation to the subject.Type: GrantFiled: March 31, 2003Date of Patent: September 14, 2010Assignee: Council of Scientific and Industrial ResearchInventors: Vishwa Nath Gupta, Krishan Avtar Suri, Bishan Datt Gupta, Bupinder Singh Jaggi, Naresh Kumar Satti, Bal Krishan Chandan, Neelam Sharma, Vikram Bhardwaj, Om Parkash Suri, Ghulam Nabi Qazi, Jyotsna Suri, Madalsa Bargotra
-
Patent number: 7514105Abstract: The present invention relates to a bioenhancing/bioavailability-facilitating composition comprising: an effective amount of an extract and/or at least one bioactive fraction from Cuminum cyminum; one or more additive selected from drugs, nutrients, vitamins, nutraceuticals, herbal drugs/products, micro nutrients, antioxidants along with pharmaceuticaly acceptable additives/excipient, and optionally, an effective amount of piperine or extract/fraction of piper nigrum or piper longum; and a process for the preparation of such extracts and active fractions from plant Cuminum cyminum.Type: GrantFiled: February 23, 2006Date of Patent: April 7, 2009Assignee: Council of Scientific and Industrial ResearchInventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Subhash Chander Sharma, Sheikh Tasaduq Abdullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria, Surjit Singh, Anamika Khajuria, Bal Krishan Kapahi
-
Publication number: 20080292736Abstract: The present invention relates to the use of extracts of Carum carvi as bioenhancers, either alone or in combination with piperine or Zingiber officinale extract to improve the bioavailability of a wide variety of drugs.Type: ApplicationFiled: January 28, 2008Publication date: November 27, 2008Inventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Subhash Chandra Sharma, Tasaduaq Abdullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria
-
Publication number: 20080138452Abstract: The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicityType: ApplicationFiled: December 21, 2007Publication date: June 12, 2008Inventors: Rakesh Kamal Johri, Sheikh Tasaduq Abdullah, Kuldeep Singh, Devinder Kumar Gupta, Bal Krishan Kapahi, Dilip Manikrao Mondhe, Satinder Mohan Jain, Om Parkash Suri, Kasturi Lal Bedi, Ghulam Nabi Qazi
-
Patent number: 7259148Abstract: The present invention provides a method for treating and/or preventing hepatic disease conditions in a subject mammals including human beings, said method comprising the steps of administering to the mammal an effective dosage of composition comprising 2?-p-Hydroxy benzoyl mussaenosidic acid from plant Vitex negundo optionally as individual or in combination with one or more pharmaceutically additives.Type: GrantFiled: May 12, 2003Date of Patent: August 21, 2007Assignee: Council of Scientific & Industrial ResearchInventors: Anil Prabhakar, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Swadesh Malhotra, Kuldip Kumar Gupta, Vijay Kumar Sharma, Rakesh Kamal Johri, Bupinder Singh Jaggi, Bal Krishan Chandan, Shankar Lal, Kasturi Lal Bedi, Om Parkash Suri, Gulam Nabi Qazi
-
Patent number: 7119075Abstract: The present invention relates to the use of bioenhancers to decrease the resistance of microbial strains to anti-infective such an antibiotics and antifungals by potentiating the activities of anti-infective. This may be useful to reduce resistance in bacteria and yeast to aid in the treatment of certain infections and disease and to lower the concentration of antiinfectives necessary to inhibit the growth of microbial strains.Type: GrantFiled: March 31, 2003Date of Patent: October 10, 2006Assignee: Council of Scientific and Industrial ResearchInventors: Ghulam Nabi Qazi, Om Parkash Suri, Kasturi Lal Bedi, Inshad Ali Khan, Vijeshwar Verma, Rakesh Kamal Johri, Krishan Avtar Suri, Bishan Datt Gupta, Naresh Kumar Satti, Manoj Kumar Tikoo, Subhash Chander Sharma, Ashok Kumar Tikoo
-
Patent number: 7118766Abstract: The present invention relates to a pharmaceutical composition comprising a bioactive constituent trans-tetracos-15-enoic acid and a process for the isolation of tetracos-15-enoic acid from the plant Indigofera tinctoria along with a method of treatment for hepatotoxicity.Type: GrantFiled: February 11, 2002Date of Patent: October 10, 2006Assignee: Council of Scientific & Industrial ResearchInventors: Sukhdev Swami Handa, Bupinder Singh, Bal Krishan Chandan, Ajit Kumar Saxena, Vikram Bhardwaj, V. N. Gupta, Om Parkash Suri, Naresh Kumar Satti, Krishan Avtar Suri
-
Patent number: 7070814Abstract: The present invention relates to a bioenhancing/bioavailability-facilitating composition comprising: an effective amount of an extract and/or at least one bioactive fraction from Cuminum cyminum; one or more additive selected from drugs, nutrients, vitamins, nutraceuticals, herbal drugs/products, micro nutrients, antioxidants along with pharmaceutically acceptable additives/excipient, and optionally, an effective amount of piperine or extract/fraction of piper nigrum or piper longum; and a process for the preparation of such extracts and active fractions from plant Cuminum cyminum.Type: GrantFiled: March 11, 2003Date of Patent: July 4, 2006Assignee: Council of Scientific and Industrial ResearchInventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Subhash Chander Sharma, Sheikh Tasaduq Absullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria, Surjit Singh, Anamika Khajuria, Bal Krishan Kapahi
-
Patent number: 7001619Abstract: The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity.Type: GrantFiled: March 27, 2002Date of Patent: February 21, 2006Assignee: Council of Scientific and Industrial ResearchInventors: Rakesh Kamal Johri, Sheikh Tasaduq Abdullah, Kuldeep Singh, Devinder Kumar Gupta, Bal Krishan Kapahi, Dilip Manikrao Mondhe, Satinder Mohan Jain, Om Parkash Suri, Kasturi Lal Bedi, Ghulam Nabi Qazi
-
Patent number: 6989162Abstract: A process of isolation of pure Acteoside of high hepatoprotection from plant Colerbrookea oppositifolia, said process comprising steps of drying aerial parts of the plant, grounding the dried parts into powder, percolating the powder with water or ethanol for 3-4 times to obtain an extract, filtering the extract for clearing of suspended particles to obtain supernatant, drying the supernatant at about 45 to 55° C.Type: GrantFiled: March 31, 2003Date of Patent: January 24, 2006Assignee: Council of Scientific & Industrial ResearchInventors: Ghulam Nabi Qazi, Om Parkash Suri, Kasturi Lal Bedi, Krishan Avtar Suri, Bishan Datt Gupta, Bupinder Singh Jaggi, Bal Krishan Kapahi, Naresh Kumar Satti, Musarat Amina, Bal Krishan Chandan, Neelam Sharma, Gurdarshan Singh
-
Patent number: 6949586Abstract: The present invention relates to a synergistic hepatoprotective pharmaceutical composition comprising an effective amount of trans-tetracos-15-enoic acid (TCA) and Apocynin (APO), the present invention also relates to a method of treatment for hepatotoxicity in mammals and humans.Type: GrantFiled: March 20, 2002Date of Patent: September 27, 2005Assignee: Council of Scientific ResearchInventors: Sukhdev Swami Handa, Om Parkash Suri, Vishwa Nath Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Vikram Bhardwaj, Bupinder Singh, Bal Krishan Chandan
-
Patent number: 6852759Abstract: The present invention relates to a process for the preparation of trans-alkenoic acids of general formula CH3—(CH2)n—CH?(CH2)mCO2H where n=4 to 9 m=8 to 16. More particularly, the present invention relates to a process for the preparation of trans-tetracos-15-enoic acid, which is a bioactive constituent possessing dose-related hepatoprotective activity. The present invention also relates to the use thereof for hepatoprotection.Type: GrantFiled: March 28, 2002Date of Patent: February 8, 2005Assignee: Council of Scientific and Industrial ResearchInventors: Vishwa Nath Gupta, Vikram Bhardwaj, Bhupinder Singh, Bal Krishan Chandan, Krishan Avtar Suri, Naresh Kumar Satti, Om Parkash Suri, Sukhdev Swami Handa
-
Publication number: 20040198672Abstract: The present invention relates to the use of bioenhancers to decrease the resistance of microbial strains to anti-infective such an antibiotics and antifungals by potentiating the activities of anti-infective. This may be usefuil to reduce resistance in bacteria and yeast to aid in the treatment of certain infections and disease and to lower the concentration of antiinfectives necessary to inhibit the growth of microbial strains.Type: ApplicationFiled: March 31, 2003Publication date: October 7, 2004Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCHInventors: Ghulam Nabi Qazi, Om Parkash Suri, Kasturi Lal Bedi, Inshad Ali Khan, Vijeshwar Verma, Rakesh Kamal Johri, Krishan Avtar Suri, Bishan Datt Gupta, Naresh Kumar Satti, Manoj Kumar Tikoo, Subhash Chander Sharma, Ashok Kumar Tikoo
-
Publication number: 20040191309Abstract: The present invention relates to a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) in the ratio ranging between 1:7 to 7:1 (w/w), useful in hepatoprotection; and a process for the preparation of a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) useful in hepatoprotection, said process comprising steps of grounding the particles of the t-TCA and AP into fine particles, mixing the fine particles in ratio ranging between 1:7 to 7:1 (w/w), and grinding the mixture to obtain formulation, and also, a method of hepatoprotection of a subject using the synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP), said method comprising the steps of administering the formulation to the subject.Type: ApplicationFiled: March 31, 2003Publication date: September 30, 2004Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCHInventors: Vishwa Nath Gupta, Krishan Avtar Suri, Bishan Datt Gupta, Bupinder Singh Jaggi, Naresh Kumar Satti, Bal Krishan Chandan, Neelam Sharma, Vikram Bhardwaj, Om Parkash Suri, Ghulam Nabi Qazi, Jyotsna Suri, Madalsa Bargotra
-
Publication number: 20040192619Abstract: A process of isolation of pure Acteoside of high hepatoprotection from plant Colerbrookea oppositifolia, said process comprising steps of drying aerial parts of the plant, grounding the dried parts into powder, percolating the powder with water or ethanol for 3-4 times to obtain an extract, filtering the extract for clearing of suspended particles to obtain supernatant, drying the supernatant at about 45 to 55° C.Type: ApplicationFiled: March 31, 2003Publication date: September 30, 2004Inventors: Ghulam Nabi Qazi, Om Parkash Suri, Kasturi Lal Bedi, Krishan Avtar Suri, Bishan Datt Gupta, Bupinder Singh Jaggi, Bal Krishan Kapahi, Naresh Kumar Satti, Musarat Amina, Bal Krishan Chandan, Neelam Sharma, Gurdarshan Singh
-
Publication number: 20040175446Abstract: A modified and efficient single-step process for the production of standardized pudina arka as medicated water from plant Mentha herbs with ratio of drug component in arka to total arka ranging between 1:2 to 1:20 involving complete recovery of all the active material, said method comprising steps of taking aerial parts of the plant Mentha herb, crushing it optionally, adding solvent to the plant parts in the ratio ranging between 6:1 to 25:1 to obtain mixture, macerating the mixture at an elevated temperature, while maintaining desired pH, and pressure conditions, distillating the macerated mixture continuously till requisite amount of distillate is obtained, and obtaining distillate as standard pudina arka.Type: ApplicationFiled: March 7, 2003Publication date: September 9, 2004Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCHInventors: Shri Gopal Agarwal, Rajinder Kumar Thappa, Bal Krishan Kapahi, Aruna Gupta, Om Parkash Suri, Ghulam Nabi Qazi
-
Publication number: 20040121028Abstract: The invention relates to the isolation and preparation of an active fraction from plant Cuminum cyminum, its further purification and standardization as chemically defined entity (ies) with their intended use as drug bioavailability enhancer for the drugs belonging to therapeutic categories such as antimicrobial, antifungal, anti-viral, antitubercular, antileprosy, anti-inflammatory, antiarthritic, cardiovascular, antihistaminics, respiratory distress relieving drugs, immunosuppressants, anti-ulcerogenic, anti-cancer, CNS drugs, corticosteroids, nutraceuticals in compositions to be administered orally/parenterally, topically, inhalations (including nebulizers), rectally, vaginally in human beings and/or veterinary conditions.Type: ApplicationFiled: July 16, 2003Publication date: June 24, 2004Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCHInventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Subhash Chander Sharma, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Sheikh Tasaduq Abdullah, Kuldip Singh, Rashmi Pandita, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria, Bal Krishan Kapahi, Ashok Kumar Kalsotra, Neelam Verma, Rajneesh Anand
-
Publication number: 20040052873Abstract: The present invention relates to a bioenhancing/bioavailability-facilitating composition comprising:Type: ApplicationFiled: March 11, 2003Publication date: March 18, 2004Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCHInventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tickoo, Ashok Kumar Tickoo, Subhash Chander Sharma, Sheikh Tasaduq Abdullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria, Surjit Singh, Anamika Khajuria, Bal Krishan Kapahi
-
Publication number: 20040029816Abstract: A method for treating and/or preventing hepatic disease conditions in mammals including human beings, said method comprising the steps of administering to the mammal an effective amount of 10-O-p-hydroxybenzoylaucubin compound of Formula 1, also called Agnuside, optionally individual or in combination with one or more pharmaceutically acceptable additives.Type: ApplicationFiled: May 12, 2003Publication date: February 12, 2004Inventors: Anil Prabhakar, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Swadesh Malhotra, Rakesh Kamal Johri, Bupinder Singh Jaggi, Bal Krishan Chandan, Ashok Kumar Sharma, Devinder Kumar Gupta, Bal Krishan Kapahi, Kasturi Lal Bedi, Om Parkash Suri, Gulam Nabi Qazi
-
Publication number: 20040024232Abstract: The present invention relates to a process for the preparation of trans-alkenoic acids of general formula CH3—(CH2)n—CH—(CH2)m CO2H where n=4 to 9 m−8 to 16. More particularly, the present invention relates to a process for he preparation of trans-tetracos-15-enoic acid, which is a bioactive constituent possessing dose-related hepatoprotective activity. The present invention also relates to the use thereof for hepatoprotection.Type: ApplicationFiled: March 28, 2002Publication date: February 5, 2004Inventors: Vishwa Nath Gupta, Vikram Bhardwaj, Bhupinder Singh, Bal Krishan Chandan, Krishan Avtar Suri, Naresh Kumar Satti, Om Parkash Suri, Sukhdev Swami Handa